Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer : a Prospective Study
Interventional
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Response rate
response will be assessed every 3 cycles of chemotherapy according to WHO criteria
Yes
Thierry Berghmans, MD
Study Chair
European Lung Cancer Working Party
Belgium: Federal Agency for Medicinal Products and Health Products
01082
NCT00864266
March 2009
March 2015
Name | Location |
---|